Cita APA

Tarhini, A., Toor, K., Chan, K., McDermott, D., Mohr, P., Larkin, J., . . . Atkins, M. (2021). A matching-adjusted indirect comparison of combination nivolumab plus ipilimumab with BRAF plus MEK inhibitors for the treatment of BRAF-mutant advanced melanoma(☆). ESMO Open.

Chicago Style Citation

Tarhini, A.A., et al. "A Matching-adjusted Indirect Comparison of Combination Nivolumab Plus Ipilimumab With BRAF Plus MEK Inhibitors for the Treatment of BRAF-mutant Advanced Melanoma(☆)." ESMO Open 2021.

Cita MLA

Tarhini, A.A., et al. "A Matching-adjusted Indirect Comparison of Combination Nivolumab Plus Ipilimumab With BRAF Plus MEK Inhibitors for the Treatment of BRAF-mutant Advanced Melanoma(☆)." ESMO Open 2021.